The translation of an assay from Discovery to Preclinical/Clinical is an important part of drug development. It requires an understanding of the context of use of the assay, as well as, the robustness of the technology and procedure. Often the target for these type of assays fall in the biomarker category.
KCAS has over 20 years of experience providing assay translation services.
KCAS has an integrated Drug Discovery and Development paradigm, where we are able to take a fit-for-purpose assay in Discovery through to a validated assay for Preclinical and Clinical Sample Analysis. For over 20 years we have provided assay translation services and we have the infrastructure in place support your drug development. We have  state-of-the-art technology platforms to deliver assay translational needs from not only Discovery though preclinical/clinical, but also to include translation across species and matrices as required.
We have highly experienced staff scientists, with the ability to design, develop and execute translation assays by utilizing a fit-for-purpose and flexible strategy that ultimately produces a robust and validated assay as we move through the integrated Drug Discovery and Development Paradigm. To ensure this level of expertise we have exceptional directors to lead all of our key areas.